No-reflow reversibility: A study based on serial assessment of multiple biomarkers

Journal of Cardiovascular Translational Research

Volumn 6, Issue 5, 2013, Pages 798-807

  Niccoli, Giampaolo ^a   Fracassi, Francesco ^a   Cosentino, Nicola ^a   Falcioni, Elena ^a   Roberto, Marco ^a   De Luca, Giuseppe ^b   Leone, Antonio Maria ^a   Burzotta, Francesco ^a   Porto, Italo ^a   Trani, Carlo ^a   Severino, Anna ^a   Crea, Filippo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Inflammation; Neoangiogenesis; No reflow; Primary percutaneous coronary intervention; ST elevation myocardial infarction

Indexed keywords

ANGIOPOIETIN 2; BIOLOGICAL MARKER; C REACTIVE PROTEIN; ENDOTHELIN 1; MYELOPEROXIDASE;

ADULT; ANGIOCARDIOGRAPHY; ANGIOGENESIS; ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; ELECTROCARDIOGRAPHY; ENZYME BLOOD LEVEL; FEMALE; HEART MUSCLE REPERFUSION; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; NEUTROPHIL CHEMOTAXIS; NO REFLOW PHENOMENON; OUTCOMES RESEARCH; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; VASOSPASM;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; ELECTROCARDIOGRAPHY; ENDOTHELIN-1; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MICROCIRCULATION; MIDDLE AGED; NO-REFLOW PHENOMENON; PATIENT DISCHARGE; PERCUTANEOUS CORONARY INTERVENTION; PEROXIDASE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TIME FACTORS; VESICULAR TRANSPORT PROTEINS;

EID: 84885656898     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-013-9509-5     Document Type: Article

References (41)

1. Steg, P. G., James, S. K., Atar, D., Badano, L. P., Blomstrom-Lundqvist, C., Borger, M. A., et al. (2012). ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal, 33(20), 2569-2619. doi: 10.1093/eurheartj/ehs215.
2. Niccoli, G., Burzotta, F., Galiuto, L., & Crea, F. (2009). Myocardial no-reflow in humans. Journal of the American College of Cardiology, 54(4), 281-292. doi: 10.1016/j.jacc.2009.03.054.
3. De Luca, G., van't Hof, A. W., Ottervanger, J. P., Hoorntje, J. C., Gosselink, A. T., Dambrink, J. H., et al. (2005). Unsuccessful reperfusion in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. American Heart Journal, 150(3), 557-562. doi: 10.1016/j.ahj.2004. 10.044.
4. Nijveldt, R., Beek, A. M., Hirsch, A., Stoel, M. G., Hofman, M. B., Umans, V. A., et al. (2008). Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury. Journal of the American College of Cardiology, 52(3), 181-189. doi: 10.1016/j.jacc.2008.04. 006.
5. Ndrepepa, G., Tiroch, K., Fusaro, M., Keta, D., Seyfarth, M., Byrne, R. A., et al. (2010). 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. Journal of the American College of Cardiology, 55(21), 2383-2389. doi: 10.1016/j.jacc.2009.12.054.
6. Niccoli, G., Cosentino, N., Lombardo, A., Sgueglia, G. A., Spaziani, C., Fracassi, F., et al. (2011). Angiographic patterns of myocardial reperfusion after primary angioplasty and ventricular remodeling. Coronary Artery Disease, 22(7), 507-514. doi: 10.1097/MCA.0b013e32834a37ae.
7. Poli, A., Fetiveau, R., Vandoni, P., del Rosso, G., D'Urbano, M., Seveso, G., et al. (2002). Integrated analysis of myocardial blush and ST-segment elevation recovery after successful primary angioplasty: Real-time grading of microvascular reperfusion and prediction of early and late recovery of left ventricular function. Circulation, 106(3), 313-318.
8. Galiuto, L., Lombardo, A., Maseri, A., Santoro, L., Porto, I., Cianflone, D., et al. (2003). Temporal evolution and functional outcome of no reflow: sustained and spontaneously reversible patterns following successful coronary recanalisation. Heart, 89(7), 731-737.
9. Eitel, I., Nowak, M., Stehl, C., Adams, V., Fuernau, G., Hildebrand, L., et al. (2010). Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and no-reflow assessed by contrast-enhanced magnetic resonance imaging. American Heart Journal, 159(5), 882-890. doi: 10.1016/j.ahj.2010.02.019.
10. Funayama, H., Ishikawa, S. E., Sugawara, Y., Kubo, N., Momomura, S., & Kawakami, M. (2010). Myeloperoxidase may contribute to the no-reflow phenomenon in patients with acute myocardial infarction. International Journal of Cardiology, 139(2), 187-192. doi: 10.1016/j.ijcard.2008.10.018.
11. Hoffmann, R., Haager, P., Arning, J., Christott, P., Radke, P., Blindt, R., et al. (2003). Usefulness of myocardial blush grade early and late after primary coronary angioplasty for acute myocardial infarction in predicting left ventricular function. The American Journal of Cardiology, 92(9), 1015-1019.
12. Niccoli, G., Lanza, G. A., Shaw, S., Romagnoli, E., Gioia, D., Burzotta, F., et al. (2006). Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization. European Heart Journal, 27(15), 1793-1798. doi: 10.1093/eurheartj/ehl119.
13. Lee, K. W., Lip, G. Y., & Blann, A. D. (2004). Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes. Circulation, 110(16), 2355-2360. doi: 10.1161/01.CIR.0000138112.90641.7F.
14. van't Hof, A. W., Liem, A., Suryapranata, H., Hoorntje, J. C., de Boer, M. J., & Zijlstra, F. (1998). Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation, 97(23), 2302-2306.
15. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. (1985). New England Journal of Medicine, 312(14), 932-936. doi: 10.1056/NEJM198504043121435.
16. Gibson, C. M., Murphy, S. A., Morrow, D. A., Aroesty, J. M., Gibbons, R. J., Gourlay, S. G., et al. (2004). Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction. American Heart Journal, 148(2), 336-340. doi: 10.1016/j.ahj.2003.12. 044.
17. Rentrop, K. P., Cohen, M., Blanke, H., & Phillips, R. A. (1985). Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. Journal of the American College of Cardiology, 5(3), 587-592.
18. Sorajja, P., Gersh, B. J., Costantini, C., McLaughlin, M. G., Zimetbaum, P., Cox, D. A., et al. (2005). Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction. European Heart Journal, 26(7), 667-674. doi: 10.1093/eurheartj/ehi167.
19. Ambrosio, G., Weisman, H. F., Mannisi, J. A., & Becker, L. C. (1989). Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation, 80(6), 1846-1861.
20. Ripa, R. S., Nilsson, J. C., Wang, Y., Sondergaard, L., Jorgensen, E., & Kastrup, J. (2007). Short- and long-term changes in myocardial function, morphology, edema, and infarct mass after ST-segment elevation myocardial infarction evaluated by serial magnetic resonance imaging. American Heart Journal, 154(5), 929-936. doi: 10.1016/j.ahj.2007.06.038.
21. Lee, C. H., Wong, H. B., Tan, H. C., Zhang, J. J., Teo, S. G., Ong, H. Y., et al. (2005). Impact of reversibility of no reflow phenomenon on 30-day mortality following percutaneous revascularization for acute myocardial infarction-insights from a 1,328 patient registry. Journal of Interventional Cardiology, 18(4), 261-266. doi: 10.1111/j.1540-8183.2005.00041.x.
22. De Luca, G., Van't Hof, A. W., de Boer, M. J., Ottervanger, J. P., Hoorntje, J. C., Gosselink, A. T., et al. (2004). Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty. European Heart Journal, 25(12), 1009-1013. doi: 10.1016/j.ehj.2004.03.021.
23. Tranum-Jensen, J., Janse, M. J., Fiolet, W. T., Krieger, W. J., D'Alnoncourt, C. N., & Durrer, D. (1981). Tissue osmolality, cell swelling, and reperfusion in acute regional myocardial ischemia in the isolated porcine heart. Circulation Research, 49(2), 364-381.
24. Reffelmann, T., & Kloner, R. A. (2006). The no-reflow phenomenon: a basic mechanism of myocardial ischemia and reperfusion. Basic Research in Cardiology, 101(5), 359-372. doi: 10.1007/s00395-006-0615-2.
25. Malle, E., Furtmuller, P. G., Sattler, W., & Obinger, C. (2007). Myeloperoxidase: a target for new drug development? British Journal of Pharmacology, 152(6), 838-854. doi: 10.1038/sj.bjp.0707358.
26. Zhang, R., Brennan, M. L., Shen, Z., MacPherson, J. C., Schmitt, D., Molenda, C. E., et al. (2002). Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. Journal of Biological Chemistry, 277(48), 46116-46122. doi: 10.1074/jbc.M209124200.
27. Orn, S., Manhenke, C., Greve, O. J., Larsen, A. I., Bonarjee, V. V., Edvardsen, T., et al. (2009). Microvascular obstruction is a major determinant of infarct healing and subsequent left ventricular remodelling following primary percutaneous coronary intervention. European Heart Journal, 30(16), 1978-1985. doi: 10.1093/eurheartj/ehp219.
28. Derumeaux, G. A. (2004). Assessment of reperfusion-induced myocardial injury by echocardiography. European Heart Journal, 25(9), 714-715. doi: 10.1016/j.ehj.2004.03.014.
29. Schwartz, B. G., & Kloner, R. A. (2012). Coronary no reflow. Journal of Molecular and Cellular Cardiology, 52(4), 873-882. doi: 10.1016/j.yjmcc.2011. 06.009.
30. Helisch, A., & Schaper, W. (2003). Arteriogenesis: the development and growth of collateral arteries. Microcirculation, 10(1), 83-97. doi: 10.1038/sj.mn.7800173.
31. Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000). Vascular-specific growth factors and blood vessel formation. Nature, 407(6801), 242-248. doi: 10.1038/35025215.
32. Matsunaga, T., Warltier, D. C., Tessmer, J., Weihrauch, D., Simons, M., & Chilian, W. M. (2003). Expression of VEGF and angiopoietins-1 and -2 during ischemia-induced coronary angiogenesis. American Journal of Physiology - Heart and Circulatory Physiology, 285(1), H352-H358. doi: 10.1152/ajpheart. 00621.2002.
33. Visconti, R. P., Richardson, C. D., & Sato, T. N. (2002). Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF). Proceedings of the National Academy of Sciences of the United States of America, 99(12), 8219-8224. doi: 10.1073/pnas.122109599.
34. Galaup, A., Gomez, E., Souktani, R., Durand, M., Cazes, A., Monnot, C., et al. (2012). Protection against myocardial infarction and no-reflow through preservation of vascular integrity by angiopoietin-like 4. Circulation, 125(1), 140-149. doi: 10.1161/CIRCULATIONAHA.111.049072.
35. Kim, J. S., Kim, J., Choi, D., Lee, C. J., Lee, S. H., Ko, Y. G., et al. (2010). Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial. JACC Cardiovascular Interventions, 3(3), 332-339. doi: 10.1016/j.jcin.2009.11.021.
36. Theroux, P., Armstrong, P. W., Mahaffey, K. W., Hochman, J. S., Malloy, K. J., Rollins, S., et al. (2005). Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trial. European Heart Journal, 26(19), 1964-1970. doi: 10.1093/eurheartj/ehi292.
37. Grieve, S. M., Bhindi, R., Seow, J., Doyle, A., Turner, A. J., Tomka, J., et al. (2010). Microvascular obstruction by intracoronary delivery of mesenchymal stem cells and quantification of resulting myocardial infarction by cardiac magnetic resonance. Circulation. Heart Failure, 3(3), e5-e6. doi: 10.1161/CIRCHEARTFAILURE.109.931360.
38. Moreira Rde, C., Haddad, A. F., Silva, S. A., Souza, A. L., Tuche, F. A., Oliveira, M. A., et al. (2011). Intracoronary stem-cell injection after myocardial infarction: microcirculation sub-study. Arquivos Brasileiros de Cardiologia, 97(5), 420-426.
39. Porto, I., Burzotta, F., Brancati, M., Trani, C., Lombardo, A., Romagnoli, E., et al. (2007). Relation of myocardial blush grade to microvascular perfusion and myocardial infarct size after primary or rescue percutaneous coronary intervention. The American Journal of Cardiology, 99(12), 1671-1673. doi: 10.1016/j.amjcard.2007.01.045.
40. Porto, I., Hamilton-Craig, C., Brancati, M., Burzotta, F., Galiuto, L., & Crea, F. (2010). Angiographic assessment of microvascular perfusion-myocardial blush in clinical practice. American Heart Journal, 160(6), 1015-1022. doi: 10.1016/j.ahj.2010.08.009.
41. Robbers, L. F., Eerenberg, E. S., Teunissen, P. F., Jansen, M. F., Hollander, M. R., Horrevoets, A. J., et al. (2013). Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage. European Heart Journal, 34(30), 2346-2353. doi: 10.1093/eurheartj/eht100.